Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2009
06/18/2009WO2009074969A2 Spingosine-1-phosphate, analogues and antagonists for use as medicaments
06/18/2009WO2009074862A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone
06/18/2009WO2009074853A2 Ophthalmic composition comprising phenylephrine
06/18/2009WO2009074835A1 Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity
06/18/2009WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
06/18/2009WO2009074827A2 Combination comprising a mek inhibitor and an aurora kinase inhibitor
06/18/2009WO2009074812A1 Antibacterial condensed thiazoles
06/18/2009WO2009074811A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis
06/18/2009WO2009074810A1 Antibacterial compositions
06/18/2009WO2009074809A1 Sigma ligands and ikk / nf - kb inhibitors for medical treatment
06/18/2009WO2009074794A2 Anti-inflammatory compositions and combinations
06/18/2009WO2009074792A2 Substituted benzoquinones and hydroquinones in the treatment of periodontal diseases
06/18/2009WO2009074789A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors
06/18/2009WO2009074782A1 Cannabinoid receptor modulators
06/18/2009WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
06/18/2009WO2009074743A1 Pyrazolo-pyrazines derivatives used as g protein inhibitors
06/18/2009WO2009074733A2 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same
06/18/2009WO2009074706A1 Novel dicarboxylic amino acid derivatives and the use thereof in the treatment of neurodegenerative diseases
06/18/2009WO2009074703A1 Deuterated tapazole and derivatives, preparation method therefor and use of same
06/18/2009WO2009074677A2 Pyrazolotriazines
06/18/2009WO2009074674A2 Trisubstituted piperidines as renin inhibitors
06/18/2009WO2009074662A2 Organic compounds
06/18/2009WO2009074649A1 Compounds for preventing and treating plasmodium infections
06/18/2009WO2009074644A1 Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
06/18/2009WO2009074607A1 Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
06/18/2009WO2009074605A1 Aminothiazoles and their uses
06/18/2009WO2009074594A1 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074593A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074592A1 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074591A1 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074590A1 N- (2 { [1-phenyl-1h-indaz0l-4-yl] amino} propyl) -sulfonamide derivatives as non-steroidal glucocorticoid receptor ligands for the treatment of inflammations
06/18/2009WO2009074575A2 Organic compounds
06/18/2009WO2009074519A1 Combinations of pyrazolyl or isoxazolyl p2x7 modulators with further therapeutic agents
06/18/2009WO2009074518A1 Combinations of prolinamide p2x7 modulators with further therapeutic agents
06/18/2009WO2009074517A1 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
06/18/2009WO2009074498A1 Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate
06/18/2009WO2009074487A1 Inhibitors of stearoyl-coa desaturase
06/18/2009WO2009074478A1 Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree
06/18/2009WO2009074351A2 Solid forms of tenofovir disoproxil
06/18/2009WO2009074333A1 Synthesis of paliperidone
06/18/2009WO2009074320A1 Method for odor extinction
06/18/2009WO2009074305A1 Gold xanthogenates and medicaments comprising them
06/18/2009WO2009074300A2 Hedgehog pathway antagonists and therapeutic applications thereof
06/18/2009WO2009074286A2 Pharmaceutical formulation comprising ezetimibe
06/18/2009WO2009074274A1 Functionalised solid polymer nanoparticles containing epothilones
06/18/2009WO2009074259A1 Triazolotriazines and triazolopyrazines and the use thereof
06/18/2009WO2009074253A2 Clofarabine dietherphospholipid derivatives
06/18/2009WO2009074249A1 Oxazolidinones for the treatment and/or prophylaxis of heart failure
06/18/2009WO2009074247A1 Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
06/18/2009WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
06/18/2009WO2009074234A1 Novel 2-substituted thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
06/18/2009WO2009074233A1 Surface-modified nanoparticles
06/18/2009WO2009074157A1 Fully-modified phenyl pyrrole aminoguanidines
06/18/2009WO2009074020A1 Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof
06/18/2009WO2009074019A1 Proteinase inhibitors useful for treating cancer
06/18/2009WO2009074018A1 Medical use of ginsenoside or their mixture and composition thereof
06/18/2009WO2009073973A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/18/2009WO2009073947A1 ORGANIC SALTS OF β-ALANINE
06/18/2009WO2009073946A1 Particles in a capsule
06/18/2009WO2009073944A1 USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION
06/18/2009WO2009073943A1 Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (hica)
06/18/2009WO2009073942A1 Tropane alkaloids and trigonelline combinations and methods for administering the same
06/18/2009WO2009073941A2 Ternary liposomal composition containing a polynucleotide
06/18/2009WO2009073940A2 Use of phthalimide derivatives in the treatment of diseases
06/18/2009WO2009073931A1 Nutraceutical composition and methods of use
06/18/2009WO2009073930A1 Nutraceutical composition and methods of use
06/18/2009WO2009073916A1 Improved treatment and prophylaxis
06/18/2009WO2009073911A1 Treatment and prophylaxis
06/18/2009WO2009058859A3 Dispiro 1,2,4-trioxolane antimalarials
06/18/2009WO2009054923A3 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist
06/18/2009WO2009053748A3 Novel crystalline forms
06/18/2009WO2009050567A3 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
06/18/2009WO2009046841A3 Piperidine and piperazine derivatives for treating tumours
06/18/2009WO2009045019A3 Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms
06/18/2009WO2009044019A3 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
06/18/2009WO2009044018A3 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
06/18/2009WO2009043844A3 Orodispersible tablets
06/18/2009WO2009042270A9 Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity
06/18/2009WO2009038385A3 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
06/18/2009WO2009037394A3 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
06/18/2009WO2009036996A3 Small molecule bradykinin b1 receptor antagonists
06/18/2009WO2009026179A4 Antiinfective proanthocyanidin compounds and methods of use thereof
06/18/2009WO2009025919A3 5-propargyl-pyrimidine derivatives as inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties
06/18/2009WO2009025806A3 Use of vegfr-2 inhibitors for treating metastatic cancer
06/18/2009WO2009016081A3 Benzoind0l-2-one derivatives for use in therapy
06/18/2009WO2009015485A8 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
06/18/2009WO2009012786A3 Nanoparticle-mediated treatment for inflammatory diseases
06/18/2009WO2009010298A3 Paullone derivatives and its use
06/18/2009WO2008156831A3 Renin inhibitors
06/18/2009WO2008156816A3 Renin inhibitors
06/18/2009WO2008148966A3 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, methods for the preparation thereof, and uses thereof
06/18/2009WO2008135601A3 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
06/18/2009WO2008122858A9 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
06/18/2009WO2008121348A3 Peripheral opioid receptor antagonists and uses thereof
06/18/2009WO2008099000A3 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
06/18/2009WO2008089709A3 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer
06/18/2009WO2008083370A3 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid
06/18/2009WO2008072053A8 Substituted arylpyrazoles
06/18/2009WO2008068174A9 4,5,6,7-tetrahydro-thieno [2,3-c] pyridines as h3 modulators
06/18/2009WO2008063910A3 Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
1 ... 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 ... 7860